Filing Details
- Accession Number:
- 0001628280-22-030946
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-29 16:11:12
- Reporting Period:
- 2022-11-25
- Accepted Time:
- 2022-11-29 16:11:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1213037 | Cardiff Oncology Inc. | CRDF | Biological Products, (No Disgnostic Substances) (2836) | 272004382 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1651537 | Mark Erlander | C/O Cardiff Oncology, Inc. 11055 Flintkote Ave San Diego CA 92121 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-11-25 | 10,000 | $1.43 | 24,481 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
